Suppr超能文献

去泛素化酶:从机制到小分子抑制。

Deubiquitinases: From mechanisms to their inhibition by small molecules.

机构信息

MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

出版信息

Mol Cell. 2022 Jan 6;82(1):15-29. doi: 10.1016/j.molcel.2021.10.027. Epub 2021 Nov 22.

Abstract

Deubiquitinases (DUBs) are specialized proteases that remove ubiquitin from substrates or cleave within ubiquitin chains to regulate ubiquitylation and therefore play important roles in eukaryotic biology. Dysregulation of DUBs is implicated in several human diseases, highlighting the importance of DUB function. In addition, many pathogenic bacteria and viruses encode and deploy DUBs to manipulate host immune responses and establish infectious diseases in humans and animals. Hence, therapeutic targeting of DUBs is an increasingly explored area that requires an in-depth mechanistic understanding of human and pathogenic DUBs. In this review, we summarize the multiple layers of regulation that control autoinhibition, activation, and substrate specificity of DUBs. We discuss different strategies to inhibit DUBs and the progress in developing selective small-molecule DUB inhibitors. Finally, we propose a classification system of DUB inhibitors based on their mode of action.

摘要

去泛素化酶(DUBs)是一类特异性的蛋白酶,可以从底物上移除泛素或者切割泛素链从而调控泛素化水平,因此在真核生物生物学中发挥着重要作用。DUBs 的失调与多种人类疾病相关,这凸显了 DUB 功能的重要性。此外,许多致病性细菌和病毒编码并利用 DUB 来操纵宿主的免疫反应,从而在人类和动物中引发传染病。因此,针对 DUB 的治疗性靶向是一个日益受到探索的领域,这需要深入了解人和致病性 DUB 的机制。在这篇综述中,我们总结了控制 DUB 自身抑制、激活和底物特异性的多个调控层次。我们讨论了抑制 DUB 的不同策略以及开发选择性小分子 DUB 抑制剂的进展。最后,我们提出了一种基于作用模式的 DUB 抑制剂分类系统。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验